These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 27382459)
1. Characterization of a Dmd (EGFP) reporter mouse as a tool to investigate dystrophin expression. Petkova MV; Morales-Gonzales S; Relizani K; Gill E; Seifert F; Radke J; Stenzel W; Garcia L; Amthor H; Schuelke M Skelet Muscle; 2016; 6():25. PubMed ID: 27382459 [TBL] [Abstract][Full Text] [Related]
2. Live-imaging of revertant and therapeutically restored dystrophin in the Dmd Petkova MV; Stantzou A; Morin A; Petrova O; Morales-Gonzalez S; Seifert F; Bellec-Dyevre J; Manoliu T; Goyenvalle A; Garcia L; Richard I; Laplace-Builhé C; Schuelke M; Amthor H Neuropathol Appl Neurobiol; 2020 Oct; 46(6):602-614. PubMed ID: 32573804 [TBL] [Abstract][Full Text] [Related]
3. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy. Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609 [TBL] [Abstract][Full Text] [Related]
4. Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells. Meng J; Counsell J; Morgan JE Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998454 [TBL] [Abstract][Full Text] [Related]
6. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle. Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976 [TBL] [Abstract][Full Text] [Related]
7. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Quenneville SP; Chapdelaine P; Skuk D; Paradis M; Goulet M; Rousseau J; Xiao X; Garcia L; Tremblay JP Mol Ther; 2007 Feb; 15(2):431-8. PubMed ID: 17235323 [TBL] [Abstract][Full Text] [Related]
8. Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies. Toh ZY; Thandar Aung-Htut M; Pinniger G; Adams AM; Krishnaswarmy S; Wong BL; Fletcher S; Wilton SD PLoS One; 2016; 11(1):e0145620. PubMed ID: 26745801 [TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy. Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538 [TBL] [Abstract][Full Text] [Related]
10. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays. Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737 [TBL] [Abstract][Full Text] [Related]
11. Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase. Quenneville SP; Chapdelaine P; Rousseau J; Tremblay JP Gene Ther; 2007 Mar; 14(6):514-22. PubMed ID: 17167499 [TBL] [Abstract][Full Text] [Related]
12. Dmd(mdx-beta geo): a new allele for the mouse dystrophin gene. Wertz K; Füchtbauer EM Dev Dyn; 1998 Jun; 212(2):229-41. PubMed ID: 9626497 [TBL] [Abstract][Full Text] [Related]
13. DMD transcript imbalance determines dystrophin levels. Spitali P; van den Bergen JC; Verhaart IE; Wokke B; Janson AA; van den Eijnde R; den Dunnen JT; Laros JF; Verschuuren JJ; 't Hoen PA; Aartsma-Rus A FASEB J; 2013 Dec; 27(12):4909-16. PubMed ID: 23975932 [TBL] [Abstract][Full Text] [Related]
14. Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy. Nik-Ahd F; Bertoni C Stem Cells; 2014 Jul; 32(7):1817-30. PubMed ID: 24753122 [TBL] [Abstract][Full Text] [Related]
15. Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy. Shu C; Kaxon-Rupp AN; Collado JR; Damoiseaux R; Crosbie RH Skelet Muscle; 2019 Dec; 9(1):32. PubMed ID: 31831063 [TBL] [Abstract][Full Text] [Related]
16. Mouse dystrophin enhancer preferentially targets lacZ expression in skeletal and cardiac muscle. Marshall P; Chartrand N; De Repentigny Y; Kothary R; Pelletier L; Mueller R; Worton RG Dev Dyn; 2002 May; 224(1):30-8. PubMed ID: 11984871 [TBL] [Abstract][Full Text] [Related]
17. Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection. Yanagihara I; Inui K; Dickson G; Turner G; Piper T; Kaneda Y; Okada S Gene Ther; 1996 Jun; 3(6):549-53. PubMed ID: 8789805 [TBL] [Abstract][Full Text] [Related]
18. A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system. Kudoh H; Ikeda H; Kakitani M; Ueda A; Hayasaka M; Tomizuka K; Hanaoka K Biochem Biophys Res Commun; 2005 Mar; 328(2):507-16. PubMed ID: 15694376 [TBL] [Abstract][Full Text] [Related]